BLDE · Blade Air Mobility, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $67.38M | - | $49.30M | $70.80M | $54.31M | - | $74.88M | $67.94M | $51.51M | - |
| Cost of Revenue | $53.27M | - | $37.68M | $53.06M | $42.33M | - | $55.04M | $51.59M | $41.38M | - |
| Gross Profit | $7.05M | - | $11.61M | $17.74M | $11.98M | - | $19.84M | $16.35M | $10.14M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $12.33M | - | $16.30M | $20.14M | $17.31M | - | $20.41M | $25.14M | $17.21M | - |
| Total Operating Expenses | $17.09M | - | $54.92M | $75.75M | $61.89M | - | $78.41M | $80.09M | $61.38M | - |
| D&A | $3.06M | - | $1.08M | $1.78M | $1.70M | - | $1.28M | $1.81M | $1.59M | - |
| Operating Income | ($2.97M) | - | ($5.62M) | ($4.95M) | ($7.58M) | - | ($3.54M) | ($12.15M) | ($9.87M) | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $0 | - | $0 | $21.0K | ($17.0K) | - | ($118.0K) | $52.0K | ($84.0K) | - |
| Net Income | $2.15M | - | $57.42M | ($3.74M) | ($3.49M) | - | ($1.95M) | ($11.33M) | ($4.23M) | - |
| EPS - Basic | $0.03 | - | $0.70 | ($0.05) | ($0.04) | - | ($0.03) | ($0.15) | ($0.06) | - |
| EPS - Diluted | $0.03 | - | $0.70 | ($0.05) | ($0.04) | - | ($0.03) | ($0.15) | ($0.06) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $58.72M | $30.97M | $22.75M | $58.75M | $34.83M | $18.38M | $20.03M | $26.31M | $36.76M | $27.87M |
| Accounts Receivable | $39.60M | $39.96M | $37.54M | $28.17M | $22.13M | $21.59M | $24.48M | $27.72M | $23.55M | $21.00M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $124.14M | $126.19M | $122.48M | $156.48M | $152.31M | $160.74M | $171.76M | $182.91M | $194.01M | $206.26M |
| Total Assets | $327.62M | $325.47M | $335.08M | $257.92M | $250.55M | $256.68M | $282.94M | $280.33M | $282.79M | $294.94M |
| Current Liabilities | $20.94M | $19.79M | $27.87M | $26.31M | $21.88M | $22.73M | $27.18M | $30.29M | $23.25M | $35.49M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $41.89M | $46.40M | $52.08M | $34.82M | $30.82M | $34.74M | $49.45M | $50.95M | $46.18M | $60.64M |
| Stockholders' Equity | $285.73M | $279.07M | $283.00M | $223.10M | $219.73M | $221.94M | $233.50M | $229.39M | $236.61M | $234.30M |
| Retained Earnings | ($143.40M) | ($145.55M) | ($136.72M) | ($194.13M) | ($190.39M) | ($186.90M) | ($177.10M) | ($175.15M) | ($163.99M) | ($159.75M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.88M | - | - | - | ($246.0K) | - | - | - | ($15.55M) | - |
| Investing Cash Flow | $24.73M | - | - | - | $20.41M | - | - | - | $24.56M | - |
| Financing Cash Flow | ($859.0K) | - | - | - | ($4.25M) | - | - | - | $54.0K | - |
| CapEx | $5.18M | - | - | - | $2.62M | - | - | - | $816.0K | - |
| Free Cash Flow | ($1.29M) | - | - | - | ($2.87M) | - | - | - | ($16.37M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 10.5% | - | 23.6% | 25.1% | 22.1% | - | 26.5% | 24.1% | 19.7% | - |
| Operating margin | -4.4% | - | -11.4% | -7.0% | -14.0% | - | -4.7% | -17.9% | -19.2% | - |
| EBITDA margin | 0.1% | - | -9.2% | -4.5% | -10.8% | - | -3.0% | -15.2% | -16.1% | - |
| Net margin | 3.2% | - | 116.5% | -5.3% | -6.4% | - | -2.6% | -16.7% | -8.2% | - |
| Free cash flow margin | -1.9% | - | - | - | -5.3% | - | - | - | -31.8% | - |
| FCF / Net income | -0.60 | - | - | - | 0.82 | - | - | - | 3.87 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 18.3% | - | 33.1% | 28.4% | 31.9% | - | 27.3% | 37.0% | 33.4% | - |
| Effective tax rate | 0.0% | - | 0.0% | - | - | - | - | - | - | - |
| Return on assets | 0.7% | - | 17.1% | -1.5% | -1.4% | - | -0.7% | -4.0% | -1.5% | - |
| Return on equity | 0.8% | - | 20.3% | -1.7% | -1.6% | - | -0.8% | -4.9% | -1.8% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 5.93 | 6.38 | 4.39 | 5.95 | 6.96 | 7.07 | 6.32 | 6.04 | 8.35 | 5.81 |
| Quick ratio | 5.93 | 6.38 | 4.39 | 5.95 | 6.96 | 7.07 | 6.32 | 6.04 | 8.35 | 5.81 |
| Cash ratio | 2.80 | 1.56 | 0.82 | 2.23 | 1.59 | 0.81 | 0.74 | 0.87 | 1.58 | 0.79 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.15 | 1.17 | 1.18 | 1.16 | 1.14 | 1.16 | 1.21 | 1.22 | 1.20 | 1.26 |
| Liabilities / Assets | 0.13 | 0.14 | 0.16 | 0.13 | 0.12 | 0.14 | 0.17 | 0.18 | 0.16 | 0.21 |
| Efficiency | ||||||||||
| Asset turnover | 0.21 | - | 0.15 | 0.27 | 0.22 | - | 0.26 | 0.24 | 0.18 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 215d | - | 278d | 145d | 149d | - | 119d | 149d | 167d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 24.1% | - | -34.2% | 4.2% | 5.4% | - | 4.8% | 11.4% | 13.8% | - |
| Revenue CAGR (3y) | 14.2% | - | 34.4% | 25.7% | 26.8% | - | 79.5% | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | -41.1% | - | -41.5% | 8.5% | 18.1% | - | 114.1% | 57.7% | 41.5% | - |
| Operating income growth (YoY) | 60.8% | - | -58.9% | 59.2% | 23.2% | - | 52.5% | 0.5% | 23.1% | - |
| Net income growth (YoY) | - | - | - | 67.0% | 17.5% | - | - | 7.4% | 58.5% | - |
| EPS growth (YoY) | - | - | - | 66.7% | 33.3% | - | - | 11.8% | 57.1% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | 54.8% | - | - | - | 82.5% | - | - | - | 6.5% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 30.0% | 25.7% | 21.2% | -2.7% | -7.1% | -5.3% | -11.2% | -12.0% | -12.4% | -14.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$197.14M totalLogistics$176.79M · 89.7%
Clinical$20.35M · 10.3%
Product / service
$20.35M totalOther Clinical$11.38M · 55.9%
Transplant Clinical$8.96M · 44.1%
Peer comparison
Same SIC group: Services-Health Services
Comparing Blade Air Mobility against the 5 most active filers in the same SIC group.